Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Younossi, 2018, Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, 15, 11, 10.1038/nrgastro.2017.109 Huang, 2021, Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, 18, 223, 10.1038/s41575-020-00381-6 Demir, 2015, Nonalcoholic fatty liver disease—current status and future directions, J Dig Dis, 16, 541 Angulo, 1999, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, 30, 1356, 10.1002/hep.510300604 Chalasani, 2018, The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases, Hepatology, 67, 328, 10.1002/hep.29367 Tilg, 2010, Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis, Hepatology, 52, 1836, 10.1002/hep.24001 Tilg, 2021, Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade, Hepatology, 73, 833, 10.1002/hep.31518 Polyzos, 2019, Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics, Metabolism, 92, 82, 10.1016/j.metabol.2018.11.014 Adolph, 2017, Adipokines and non-alcoholic fatty liver disease: multiple interactions, Int J Mol Sci, 18, 1649, 10.3390/ijms18081649 Boutari, 2018, Association of adipokines with development and progression of nonalcoholic fatty liver disease, Endocrinol Metab, 33, 33, 10.3803/EnM.2018.33.1.33 Chiang, 2010, The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population, Clin Biochem, 43, 1399, 10.1016/j.clinbiochem.2010.09.003 Kumar, 2020, Association of high-sensitivity C-reactive protein (hs-CRP) with non-alcoholic fatty liver disease (NAFLD) in Asian Indians: a cross-sectional study, J Family Med Prim Care, 9, 390, 10.4103/jfmpc.jfmpc_887_19 Barbaresko, 2013, Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review, Nutr Rev, 71, 511, 10.1111/nure.12035 Leoni, 2018, Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis, World J Gastroenterol, 24, 3361, 10.3748/wjg.v24.i30.3361 Marchesini, 2016, EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease, Obes Facts, 9, 65, 10.1159/000443344 Purcell, 2014, The effect of rate of weight loss on long-term weight management: a randomised controlled trial, Lancet Global Health, 2, 954 George, 2018, Practical dietary recommendations for the prevention and management of nonalcoholic fatty liver disease in adults, Adv Nutr, 9, 30, 10.1093/advances/nmx007 Cicero, 2018, Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence, Nutrients, 10, 1153, 10.3390/nu10091153 Reddy, 2019, Effect of dietary intervention, with or without co-interventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: a systematic literature review, Nutr Rev, 77, 765, 10.1093/nutrit/nuz029 Page, 2021, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 372, n71, 10.1136/bmj.n71 Stone, 2002, Popping the (PICO) question in research and evidence-based practice, Appl Nursi Res, 15, 197, 10.1053/apnr.2002.34181 2016, Evidence analysis manual: steps in the academy evidence analysis process, Acad Nutr Diet, 2022 Merlin, 2009 Arslan, 2017, Comparative effectiveness of diet alone and diet plus metformin treatment on omentin levels in type 2 diabetes patients with nonalcoholic fatty liver disease: a prospective randomized trial, Period Biol, 119, 9, 10.18054/pb.v119i1.4180 Daneshi-Maskooni, 2018, Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial, Nutr Metabol, 15, 63, 10.1186/s12986-018-0297-4 Pervez, 2018, Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease, Turkish J Gastroenterol, 29, 170, 10.5152/tjg.2018.17297 Pervez, 2020, Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial, Complement Ther Med, 52, 10.1016/j.ctim.2020.102494 Amiri-Moghadam, 2015, Effects of L-carnitine supplementation on inflammatory factors and malondialdehyde in patients with nonalcoholic steatohepatitis (NASH), Curr Top Nutraceut Res, 13, 135 Jazayeri-Tehrani, 2019, Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial, Nutr Metab, 16, 8, 10.1186/s12986-019-0331-1 Askari, 2014, Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients, Nutr Res, 34, 143, 10.1016/j.nutres.2013.11.005 Ekhlasi, 2017, Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease, EXCLI J, 16, 278 Hosseinabadi, 2020, Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: a randomized, controlled trial, Complement Ther Med, 49, 10.1016/j.ctim.2019.102290 Hosseinabadi, 2020, Effects of green coffee extract supplementation on glycemic indexes, leptin, and obesity values in patients with non-alcoholic fatty liver disease, J Herbal Med, 22 Chiou, 2021, Hepatoprotective effect of antrodia cinnamomea mycelium in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial, J Am College Nutr, 40, 349, 10.1080/07315724.2020.1779850 Li, 2015, Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis, World J Gastroenterol, 21, 7008, 10.3748/wjg.v21.i22.7008 Tufanaru, 2015, Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness, Int J Evid Based Healthc, 13, 196, 10.1097/XEB.0000000000000065 Higgins, 2008 Duval, 2000, Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis, Biometrics, 56, 455, 10.1111/j.0006-341X.2000.00455.x Eslami, 2019, Effect of soy milk on metabolic status of patients with nonalcoholic fatty liver disease: a randomized clinical trial, J Am Coll Nutr, 38, 51, 10.1080/07315724.2018.1479990 Maleki, 2019, Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial, Complement Ther Med, 44, 44, 10.1016/j.ctim.2019.02.020 Marin-Alejandre, 2019, The metabolic and hepatic impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: the Fatty Liver in Obesity (FLiO) randomized controlled trial, Nutrients, 11, 2543, 10.3390/nu11102543 Marin-Alejandre, 2021, Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: a randomized trial, Liver Int, 41, 1532, 10.1111/liv.14818 Ristic-Medic, 2020, Calorie-restricted mediterranean and low-fat diets affect fatty acid status in individuals with nonalcoholic fatty liver disease, Nutrients, 13, 15, 10.3390/nu13010015 Kani, 2014, Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: a parallel randomized trial, Nutrition, 30, 814, 10.1016/j.nut.2013.11.008 Baldry, 2017, Effects of short-term energy restriction on liver lipid content and inflammatory status in severely obese adults: results of a randomized controlled trial using 2 dietary approaches, Diabetes Obes Metab, 19, 1179, 10.1111/dom.12918 Spadaro, 2008, Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease, Diges Liver Dis, 40, 194, 10.1016/j.dld.2007.10.003 Abedi, 2018, The effect of conjugated linoleic acid (CLA) on inflammatory factors in non-alcoholic fatty liver disease (NAFLD): a randomized controlled clinical trial, Progr Nutr, 20, 173 Malaguarnera, 2012, Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis, Dig Dis Sci, 57, 545, 10.1007/s10620-011-1887-4 Kugelmas, 2003, Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E, Hepatology, 38, 413, 10.1053/jhep.2003.50316 Chan, 2010, Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet, Diab Care, 33, 1134, 10.2337/dc09-1765 Nomi-Golzar, 2021, Effects of hydroxy citric acid on body weight and serum hepcidin level in women with non-alcoholic fatty liver disease a randomized clinical trial, Adv Integr Med, 8, 122, 10.1016/j.aimed.2020.07.013 Garinis, 2010, Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study, Int J Obes, 34, 1255, 10.1038/ijo.2010.40 Sofi, 2010, Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study, Int J Food Sci Nutr, 61, 792, 10.3109/09637486.2010.487480 Razavi Zade, 2016, The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial, Liver Int, 36, 563, 10.1111/liv.12990 Behrouz, 2020, Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: a randomized clinical trial, J Food Sci, 85, 3611, 10.1111/1750-3841.15367 Cerletti, 2020, Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease, Br J Nutr, 123, 190, 10.1017/S0007114519002484 Darand, 2019, Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: results from a randomized, double-blind, placebo-controlled, clinical trial, Complement Ther Med, 44, 204, 10.1016/j.ctim.2019.04.014 Duseja, 2019, High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study, BMJ Open Gastroenterol, 6, e000315, 10.1136/bmjgast-2019-000315 Faghihzadeh, 2014, Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease, Nutr Res, 34, 837, 10.1016/j.nutres.2014.09.005 Haidari, 2020, An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trial, Nutr Res, 73, 15, 10.1016/j.nutres.2019.08.009 Rafie, 2020, Effect of ginger powder supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial, Clin Exp Gastroenterol, 13, 35, 10.2147/CEG.S234698 Rahmanabadi, 2019, Oral α-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology features, Food Function, 10, 4941, 10.1039/C9FO00449A Rezaei, 2019, Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: a randomized clinical trial, Nutrition, 57, 154, 10.1016/j.nut.2018.02.021 Rezaei, 2020, Flaxseed oil in the context of a weight loss programme ameliorates fatty liver grade in patients with non-alcoholic fatty liver disease: a randomised double-blind controlled trial, Br J Nutr, 123, 994, 10.1017/S0007114520000318 Amanat, 2018, Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: a randomized, controlled trial, Clinical Nutrition, 37, 1210, 10.1016/j.clnu.2017.05.028 Behrouz, 2017, Effects of probiotic and prebiotic supplementation on leptin, adiponectin, and glycemic parameters in non-alcoholic fatty liver disease: a randomized clinical trial, Middle East J Dig Dis, 9, 151, 10.15171/mejdd.2017.66 Eslamparast, 2014, Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study, Am J Clin Nutr, 99, 535, 10.3945/ajcn.113.068890 Malaguarnera, 2010, L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial, Am J Gastroenterol, 105, 1338, 10.1038/ajg.2009.719 Mofidi, 2017, Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial, Br J Nutr, 117, 662, 10.1017/S0007114517000204 Rahimlou, 2016, Ginger supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study, Hepatitis Monthly, 16, 10.5812/hepatmon.34897 Shahmohammadi, 2017, Effects of green coffee bean extract supplementation on patients with non-alcoholic fatty liver disease: a randomized clinical trial, Hepatitis Monthly, 17, 10.5812/hepatmon.45609 Abhari, 2020, The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: a randomized, placebo-controlled, clinical trial, Clin Nutr ESPEN, 39, 53, 10.1016/j.clnesp.2020.06.020 Ferro, 2020, Randomized clinical trial: bergamot citrus and wild cardoon reduce liver steatosis and body weight in non-diabetic individuals aged over 50 years, Front Endocrinol, 11, 494, 10.3389/fendo.2020.00494 Kavyani, 2021, Co-supplementation of camelina oil and a prebiotic is more effective for in improving cardiometabolic risk factors and mental health in patients with NAFLD: a randomized clinical trial, Food Function, 12, 8594, 10.1039/D1FO00448D Moradi, 2021, A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: a double-blind, placebo-controlled trial, J Trace Elem Med Biol, 63 Pour, 2020, The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: a double-blind randomized clinical trial, Phytoth Res, 34, 3367, 10.1002/ptr.6791 Bakhshimoghaddam, 2018, Daily consumption of synbiotic yogurt decreases liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial, J Nutr, 148, 1276 Yari, 2021, The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial, Eur J Clin Nutr, 75, 99, 10.1038/s41430-020-0679-3 Markova, 2017, Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes, Gastroenterology, 152, 571, 10.1053/j.gastro.2016.10.007 Kaliora, 2016, The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention, Food Function, 7, 4533, 10.1039/C6FO01040G Yari, 2016, Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study, Int J Food Sci Nutr, 67, 461, 10.3109/09637486.2016.1161011 Marina, 2014, Effects of dietary fat and saturated fat content on liver fat and markers of oxidative stress in overweight/obese men and women under weight-stable conditions, Nutrients, 6, 4678, 10.3390/nu6114678 Takemura, 2010, Lactobacillus plantarumstrain No. 14 reduces adipocyte size in mice fed high-fat diet, Exp Biol Med, 235, 849, 10.1258/ebm.2010.009377 Hadi, 2019, Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD, Crit Rev Food Sci Nutr, 59, 2494, 10.1080/10408398.2018.1458021 Mokhtari, 2017, Nonalcoholic fatty liver disease, the gut microbiome, and diet, Adv Nutr: Int Rev J., 8, 240, 10.3945/an.116.013151 Khan, 2019, The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease – a systematic review and meta-analysis, Eur J Gastroenterol Hepatol, 31, 703, 10.1097/MEG.0000000000001371 Li, 2014, Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease, Food Chem Toxicol, 63, 166, 10.1016/j.fct.2013.08.036 Dietrich, 2005, The effect of weight loss on a stable biomarker of inflammation, c-reactive protein, Nutr Rev, 63, 22, 10.1111/j.1753-4887.2005.tb00107.x Kistler, 2011, Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease, Am J Gastroenterol, 106, 460, 10.1038/ajg.2010.488 George, 2018, Non-alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence, Intern Med J, 48, 1369, 10.1111/imj.13973 Skopec, 2020, The role of geographic bias in knowledge diffusion: a systematic review and narrative synthesis, Res Integr Peer Rev, 5, 2, 10.1186/s41073-019-0088-0 Papamiltiadous, 2016, A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol, BMC Gastroenterol, 16, 14, 10.1186/s12876-016-0426-3